Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 152

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 152
---
 Statements and Schedules

 Page(s)Consolidated Financial Statements of Precigen, Inc. and SubsidiariesF-2Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34)F-3Consolidated Balance Sheets as of December 31, 2024 and 2023F-5Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023, and 2022F-7Consolidated Statements of Comprehensive (Loss) Income for the Years Ended December 31, 2024, 2023, and 2022F-8Consolidated Statements of Mezzanine Equity and Shareholders' and Total Equity for the Years Ended December 31, 2024, 2023, and 2022F-9Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023, and 2022F-12Notes to the Consolidated Financial StatementsF-15

F-1

Precigen, Inc. and Subsidiaries

Consolidated Financial Statements

December 31, 2024, 2023, and 2022 

F-2

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

To the shareholders and the Board of Directors of Precigen, Inc. 

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Precigen, Inc. and subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income (loss), shareholders' equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred net losses, cash used in operations, and had an accumulated deficit that raise substantial doubt about its ability to